The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function
趋化因子受体拮抗剂 TAK-779 可通过减少炎症细胞向中枢神经系统的迁移来减轻实验性自身免疫性脑脊髓炎,而不会影响 T 细胞功能
期刊:British Journal of Pharmacology
影响因子:6.8
doi:10.1111/j.1476-5381.2009.00528.x
Jia Ni, Yi-Na Zhu, Xiang-Gen Zhong, Yu Ding, Li-Fei Hou, Xian-Kun Tong, Wei Tang, Shiro Ono, Yi-Fu Yang, Jian-Ping Zuo